GLP-1 Demand Boosts Dis-Chem’s South Africa Pharmacy Revenue

Dis-Chem Pharmacies Ltd. said surging demand for GLP-1 medicines is helping drive double-digit growth in its dispensary revenue as South Africans increasingly turn to the expensive drugs used to treat diabetes and obesity.

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.